These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2773153)

  • 1. [Ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)] guanine. A new antiviral agent against Cytomegalovirus].
    Petersen CS; Skinhøj P
    Ugeskr Laeger; 1989 Aug; 151(34):2156-8. PubMed ID: 2773153
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Plotkin SA; Drew WL; Felsenstein D; Hirsch MS
    J Infect Dis; 1985 Oct; 152(4):833-4. PubMed ID: 2995505
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the cytotoxicity of a new anti-herpetic agent, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, on the rabbit cornea].
    Naito T; Shiota H; Kanematsu S; Mimura Y; Ogawa T
    Nippon Ganka Gakkai Zasshi; 1988 Apr; 92(4):573-7. PubMed ID: 2841833
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
    Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
    Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.
    Duke AE; Smee DF; Chernow M; Boehme R; Matthews TR
    Antiviral Res; 1986 Aug; 6(5):299-308. PubMed ID: 3021055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)guanine] on viral DNA and protein synthesis in cells infected with herpes simplex virus.
    Chun YS; Park NH
    Antimicrob Agents Chemother; 1987 Feb; 31(2):349-51. PubMed ID: 3032100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV retinitis treated with ganciclovir [9(1,3-dihydroxy-2-propoxymethyl) guanine] in patients with AIDS.
    Bach MC; Hedstrom PS
    Ann Ophthalmol; 1987 Oct; 19(10):369-73,375. PubMed ID: 2825580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons.
    Rasmussen L; Chen PT; Mullenax JG; Merigan TC
    Antimicrob Agents Chemother; 1984 Oct; 26(4):441-5. PubMed ID: 6097163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.
    Woolf NK; Ochi JW; Silva EJ; Sharp PA; Harris JP; Richman DD
    Antimicrob Agents Chemother; 1988 Jun; 32(6):865-72. PubMed ID: 2843084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.
    Mar EC; Cheng YC; Huang ES
    Antimicrob Agents Chemother; 1983 Oct; 24(4):518-21. PubMed ID: 6316844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to antiviral drugs at last.
    N Z Med J; 1989 Sep; 102(875):487. PubMed ID: 2550860
    [No Abstract]   [Full Text] [Related]  

  • 13. Fine structure of cells infected with human cytomegalovirus after treatment with 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Mobberley MA; Ryder TA; Hart H; Tyms AS
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1553-62. PubMed ID: 3035059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Andrei G; Snoeck R
    Eur J Med Chem; 2009 Aug; 44(8):3313-7. PubMed ID: 19339082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells.
    Cheng YC; Grill SP; Dutschman GE; Frank KB; Chiou JF; Bastow KF; Nakayama K
    Antimicrob Agents Chemother; 1984 Sep; 26(3):283-8. PubMed ID: 6095751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.
    Freitas VR; Smee DF; Chernow M; Boehme R; Matthews TR
    Antimicrob Agents Chemother; 1985 Aug; 28(2):240-5. PubMed ID: 3010840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol.
    Shakiba S; Freeman WR; Flores-Aguilar M; Munguia D; Tatebayashi M; Besen G; Amani R; Wiley CA; Vuong C; Aldern KA
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1383-5. PubMed ID: 7574537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase.
    Smee DF; Knight SS; Duke AE; Robinson WS; Matthews TR; Marion PL
    Antimicrob Agents Chemother; 1985 Feb; 27(2):277-9. PubMed ID: 2580482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cytomegalovirus gastrointestinal ulceration in a heart transplant patient.
    Sinnott JT; Cullison JP; Rogers K
    J Heart Transplant; 1987; 6(3):186-8. PubMed ID: 2821210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.